中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Design, Synthesis and Antitumor Activity of Pyrrolopyrazinone-chalcone Hybrids

文献类型:期刊论文

作者Meng Ying1; Zhang Hongwei1; Liu Zehua1; Zeng Shanchao1; Zhang Hongwei1; Sun Chiyu1; Zhang Lijuan1; Zhao Mingming1; Wang Guan2; Jiang Mengying2
刊名CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
出版日期2014
卷号30期号:4页码:624-631
关键词DERIVATIVES CELL HYDROXYCHALCONES AGENTS Pyrrolopyrazinone-chalcone hybrid Antitumor Marine sponge Combination principle
ISSN号1005-9040
其他题名Design, Synthesis and Antitumor Activity of Pyrrolopyrazinone-chalcone Hybrids
英文摘要A series of pyrrolopyrazinone-chalcone hybrids(12a-12q) was designed, synthesized and screened for their antitumor activity against SKOV-3, A549 and HeLa cell lines in vitro. Compared with the pyrrolopyrazinone(10a) and 5-fluorouracil(5-FU), nearly all the tested compounds showed significantly-improved antitumor activities. The most promising compounds 12e and 12k(IC50=0.25 and 0.88 mu mol/L) respectively show activities of 123 and 35 times that of compound 10a(IC50=30.74 mu mol/L) against HeLa cell line. The result reveals that the presence of chalcone moiety is beneficial to their activity and selectivity.
资助项目[Program for Liaoning Innovative Research Team in University, China]
语种英语
CSCD记录号CSCD:5214900
源URL[http://ir.imr.ac.cn/handle/321006/152293]  
专题金属研究所_中国科学院金属研究所
作者单位1.中国科学院金属研究所
2.吉林大学
推荐引用方式
GB/T 7714
Meng Ying,Zhang Hongwei,Liu Zehua,et al. Design, Synthesis and Antitumor Activity of Pyrrolopyrazinone-chalcone Hybrids[J]. CHEMICAL RESEARCH IN CHINESE UNIVERSITIES,2014,30(4):624-631.
APA Meng Ying.,Zhang Hongwei.,Liu Zehua.,Zeng Shanchao.,Zhang Hongwei.,...&Song Hongrui.(2014).Design, Synthesis and Antitumor Activity of Pyrrolopyrazinone-chalcone Hybrids.CHEMICAL RESEARCH IN CHINESE UNIVERSITIES,30(4),624-631.
MLA Meng Ying,et al."Design, Synthesis and Antitumor Activity of Pyrrolopyrazinone-chalcone Hybrids".CHEMICAL RESEARCH IN CHINESE UNIVERSITIES 30.4(2014):624-631.

入库方式: OAI收割

来源:金属研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。